Psychedelics for Depression & Anxiety

4 million people suffer from depression & anxiety in the UK. Research has shown the potential of LSD and psilocybin to treat these conditions, yet it is being hindered by the restrictive Schedule 1 status of the substances.

By rescheduling LSD and psilocybin from Schedule 1 to Schedule 2, research would become faster and cheaper, and doctors would be able to start prescribing these substances when they see fit.

Use this tool to ask your MP to sign the Psychedelic Society's petition to reschedule the psychedelic substances LSD and psilocybin from Schedule 1 to Schedule 2. Enter your postcode to get started.

Powered by Writerep. PPC data provided by Democracy Club